Evidence map›Paper›PMID 41608349›Full record

ArticleWorld journal of clinical oncology2026

Ferritin as a novel predictive index for nasopharyngeal carcinoma survival and therapeutic efficacy of different chemotherapy regimens.

Qi Tang, Yao Wu, Lin Chen, Qun-Ying Jia, Fa-Qing Tang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of clinical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Qi TangDepartment of Clinical Laboratory and Hunan Key Laboratory of Oncotarget Gene, Hunan Cancer Hospital & The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013, Hunan Province, China.
Yao WuDepartment of Clinical Laboratory and Hunan Key Laboratory of Oncotarget Gene, Hunan Cancer Hospital & The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013, Hunan Province, China.
Lin ChenDepartment of Clinical Laboratory and Hunan Key Laboratory of Oncotarget Gene, Hunan Cancer Hospital & The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013, Hunan Province, China.
Qun-Ying JiaDepartment of Clinical Laboratory and Hunan Key Laboratory of Oncotarget Gene, Hunan Cancer Hospital & The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013, Hunan Province, China.
Fa-Qing TangDepartment of Clinical Laboratory and Hunan Key Laboratory of Oncotarget Gene, Hunan Cancer Hospital & The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013, Hunan Province, China. tangfq@hnca.org.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn the treatment of nasopharyngeal carcinoma (NPC), there is a lack of effective assessment of the long-term effects on patients. Searching for an effective evaluation scheme and screening a reliable index for various therapeutic regimens is an urgent clinical issue that needs to be resolved.

aimTo establish an effective evaluation scheme and screen a reliable index for NPC patients across various therapeutic regimens.

methodsThis population-based retrospective cohort study included NPC survivors (

resultsNPC patients were divided into two groups: Survivors (615, 53.85%) and non-survivors (527, 46.15%) based on their 5-year mortality. The 5-year mortality rate of males (71.35%) was higher than that of females (28.65%). The tumor stage of the non-survivors converged to TNM stages III and IV. Non-survivors displayed significantly higher levels of Ferritin, lactate dehydrogenase, and carcinoembryonic antigen than the survivors (

conclusionThe chemotherapy regimens of NF, TN, and TP for NPC are associated with the prognosis of NPC. The Ferritin index is an important indicator for predicting NPC survival.

Indexed as

Decision curve analysis curvesFerritinNasopharyngeal carcinomaPredictive modelReceiver operating characteristic curvesRestricted cubic splineRetrospective studySurvival indicators

Identifiers

PMID41608349
PMCPMC12836027

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.